Richard Gaynor's Net Worth
$1.01 Million
Who is Richard Gaynor?
Richard Gaynor has an estimated net worth of $1.01 Million. This is based on reported shares across multiple companies, which include Zai Lab Ltd, Alkermes plc., Neon Therapeutics, Inc., and INFINITY PHARMACEUTICALS, INC..
SEC CIK
Richard Gaynor's CIK is 0001741284
Past Insider Trading and Trends
2020 was Richard Gaynor's most active year for acquiring shares with 6 total transactions. Richard Gaynor's most active month to acquire stocks was the month of May. 2020 was Richard Gaynor's most active year for disposing of shares, totalling 6 transactions. Richard Gaynor's most active month to dispose stocks was the month of April. 2023 saw Richard Gaynor paying a total of $499,984.35 for 43,577 shares, this is the most they've acquired in one year. In 2023 Richard Gaynor cashed out on 7,387 shares for a total of $42,728.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zai Lab Ltd (ZLAB) Snapshot price: $20.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +76.41% | 21.25K |
—
|
—
| 49.07K |
Jun 18
| |||
Form 4
| +212.11% | 18.9K |
$26.45 | $499,984.35 | 27.82K |
Jun 29
| |||
Form 4
|
∞
| 8.91K |
—
|
—
| 8.91K |
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alkermes plc. (ALKS) Snapshot price: $26.735
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.79% | 4.64K |
$24.10 | -$35,306.50 | 25K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17 - May 31
| |||
Form 4
| +28.60% | 4.53K |
$29.88 | -$42,728.40 | 20.36K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
| +77.08% | 6.89K |
$27.19 | -$18,897.05 | 15.83K |
Jun 14
| |||
Form 4
| +90.19% | 4.24K |
$22.11 | -$29,605.29 | 8.94K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
∞
| 4.7K |
$21.92 | -$30,775.68 | 4.7K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neon Therapeutics, Inc. No price found
President R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -210.41K |
—
|
—
|
0
|
May 6
| |||
Form 4
| -2.60% | -5.63K |
$1.50 | -$8,437.50 | 210.41K |
Feb 29
| |||
Form 4
| -2.47% | -5.46K |
$1.51 | -$8,252.15 | 216.03K |
Feb 25
| |||
Form 4
| +41.53% | 65K |
—
|
—
| 221.5K |
Jan 12
| |||
Form 4
| -29.45% | -65.32K |
$1.31 | -$85,372.76 | 156.5K |
Nov 25 - Nov 27
| |||
Form 4
| +51.08% | 75K |
—
|
—
| 221.82K |
Nov 25
| |||
Form 4
| +64.37% | 57.5K |
—
|
—
| 146.82K |
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||